Short Interest in FUJIFILM Holdings Co. (OTCMKTS:FUJIY) Expands By 1,652.8%

FUJIFILM Holdings Co. (OTCMKTS:FUJIY - Get Free Report) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 219,100 shares, a growth of 1,652.8% from the May 15th total of 12,500 shares. Based on an average daily volume of 240,900 shares, the short-interest ratio is currently 0.9 days. Approximately 0.0% of the shares of the stock are sold short.

Analyst Ratings Changes

Separately, Wall Street Zen cut FUJIFILM from a "buy" rating to a "hold" rating in a report on Friday, May 23rd.

FUJIFILM Price Performance

Shares of FUJIY stock traded down $0.23 during trading hours on Friday, hitting $10.80. 118,625 shares of the company's stock were exchanged, compared to its average volume of 221,936. The stock's 50-day moving average is $10.56 and its 200-day moving average is $10.45. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.45 and a quick ratio of 0.92. The stock has a market cap of $26.87 billion, a price-to-earnings ratio of 9.64, a price-to-earnings-growth ratio of 2.07 and a beta of 0.70. FUJIFILM has a 52 week low of $8.69 and a 52 week high of $13.88.

FUJIFILM (OTCMKTS:FUJIY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The technology company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.04. FUJIFILM had a return on equity of 7.62% and a net margin of 8.02%. The business had revenue of $6.06 billion for the quarter, compared to analyst estimates of $822.51 billion. As a group, research analysts forecast that FUJIFILM will post 0.66 EPS for the current year.

FUJIFILM Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.